US Stock MarketDetailed Quotes

RAPP Rapport Therapeutics

Watchlist

19.060
+0.500+2.69%

Close Aug 9 16:00 ET

697.15MMarket Cap-11062P/E (TTM)

Rapport Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-147.80%-16.35M

-266.90%-17.62M

-27.18M

-6.6M

-4.8M

Net income from continuing operations

-182.65%-18.12M

-268.78%-22.67M

---34.79M

---6.41M

---6.15M

Operating gains losses

--0

617.48%7.39M

--1.12M

--0

--1.03M

Depreciation and amortization

890.48%208K

913.33%152K

--112K

--21K

--15K

Other non cash items

--159K

--156K

--267K

----

Change In working capital

89.34%-123K

-648.10%-3.16M

--2.65M

---1.15M

---422K

-Change in prepaid assets

173.95%900K

-241.58%-2.07M

---3.2M

---1.22M

---606K

-Change in payables and accrued expense

-2,305.00%-882K

-367.70%-953K

--6.24M

--40K

--356K

-Change in other current assets

4.35%24K

115.70%27K

---240K

--23K

---172K

-Change in other current liabilities

---165K

---161K

---144K

--0

Cash from discontinued investing activities

Operating cash flow

-147.80%-16.35M

-266.90%-17.62M

---27.18M

---6.6M

---4.8M

Investing cash flow

Cash flow from continuing investing activities

-124,439.53%-107.1M

-68,631.15%-41.93M

-78.86M

-86K

-61K

Net PPE purchase and sale

-1,024.42%-967K

-1,657.38%-1.07M

---1.64M

---86K

---61K

Net investment purchase and sale

---106.14M

---40.85M

---77.22M

--0

Cash from discontinued investing activities

Investing cash flow

-124,439.53%-107.1M

-68,631.15%-41.93M

---78.86M

---86K

---61K

Financing cash flow

Cash flow from continuing financing activities

177,158.89%159.35M

6.09%63.66M

145.14M

-90K

60.01M

Net issuance payments of debt

----

--0

----

Net common stock issuance

530,230.00%159.1M

--0

--50K

--30K

--24K

Net preferred stock issuance

63.75%-29K

6.57%63.94M

--145.22M

---80K

--60M

Net other financing activities

----

-1,472.22%-283K

---134K

---40K

---18K

Cash from discontinued financing activities

Financing cash flow

177,158.89%159.35M

6.09%63.66M

--145.14M

---90K

--60.01M

Net cash flow

Beginning cash position

-13.82%74.37M

125.47%70.25M

--31.16M

--86.3M

--31.16M

Current changes in cash

629.85%35.9M

-92.53%4.12M

--39.1M

---6.78M

--55.14M

End cash Position

38.65%110.27M

-13.82%74.37M

--70.25M

--79.53M

--86.3M

Free cash flow

-159.07%-17.32M

-284.35%-18.69M

---28.82M

---6.69M

---4.86M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-147.80%-16.35M	-266.90%-17.62M	-27.18M	-6.6M	-4.8M
Net income from continuing operations	-182.65%-18.12M	-268.78%-22.67M	---34.79M	---6.41M	---6.15M
Operating gains losses	--0	617.48%7.39M	--1.12M	--0	--1.03M
Depreciation and amortization	890.48%208K	913.33%152K	--112K	--21K	--15K
Other non cash items	--159K	--156K	--267K	----	----
Change In working capital	89.34%-123K	-648.10%-3.16M	--2.65M	---1.15M	---422K
-Change in prepaid assets	173.95%900K	-241.58%-2.07M	---3.2M	---1.22M	---606K
-Change in payables and accrued expense	-2,305.00%-882K	-367.70%-953K	--6.24M	--40K	--356K
-Change in other current assets	4.35%24K	115.70%27K	---240K	--23K	---172K
-Change in other current liabilities	---165K	---161K	---144K	--0	--0
Cash from discontinued investing activities
Operating cash flow	-147.80%-16.35M	-266.90%-17.62M	---27.18M	---6.6M	---4.8M
Investing cash flow
Cash flow from continuing investing activities	-124,439.53%-107.1M	-68,631.15%-41.93M	-78.86M	-86K	-61K
Net PPE purchase and sale	-1,024.42%-967K	-1,657.38%-1.07M	---1.64M	---86K	---61K
Net investment purchase and sale	---106.14M	---40.85M	---77.22M	--0	--0
Cash from discontinued investing activities
Investing cash flow	-124,439.53%-107.1M	-68,631.15%-41.93M	---78.86M	---86K	---61K
Financing cash flow
Cash flow from continuing financing activities	177,158.89%159.35M	6.09%63.66M	145.14M	-90K	60.01M
Net issuance payments of debt	----	----	--0	----	----
Net common stock issuance	530,230.00%159.1M	--0	--50K	--30K	--24K
Net preferred stock issuance	63.75%-29K	6.57%63.94M	--145.22M	---80K	--60M
Net other financing activities	----	-1,472.22%-283K	---134K	---40K	---18K
Cash from discontinued financing activities
Financing cash flow	177,158.89%159.35M	6.09%63.66M	--145.14M	---90K	--60.01M
Net cash flow
Beginning cash position	-13.82%74.37M	125.47%70.25M	--31.16M	--86.3M	--31.16M
Current changes in cash	629.85%35.9M	-92.53%4.12M	--39.1M	---6.78M	--55.14M
End cash Position	38.65%110.27M	-13.82%74.37M	--70.25M	--79.53M	--86.3M
Free cash flow	-159.07%-17.32M	-284.35%-18.69M	---28.82M	---6.69M	---4.86M
Currency Unit	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall